Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-25 @ 4:25 AM
NCT ID:
NCT01641120
Eligibility Criteria:
Inclusion Criteria:
* Between 18 - 65 years of age;
* Confirmed diagnosis of Relapsing Remitting Multiple Sclerosis;
* Currently being treated with Avonex® for at least 90 days;
* Using 25 gauge needles for injection of Avonex® for at least 90 days;
* Willing and able to complete study questionnaires; and
* Provided informed consent to participate in this study
Exclusion Criteria:
* Diagnosis of Progressive Multiple Sclerosis;
* History of recent illness or infection;
* History of allergic reaction to Avonex®;
* Any prior usage of a 30 gauge needle for administration of Avonex®;
* Concurrent treatment with other immunomodulating therapies;
* Pregnant or planning on becoming pregnant;
* Nursing mothers; and
* Unable to complete the requirements of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01641120
Study Brief:
Protocol Section:
NCT01641120